EU Court declares automatic extensions of pesticide approvals illegal
In a landmark ruling, the General Court of the European Union has deemed the European Commission's practice of automatically extending pesticide authorizations, including that of glyphosate and dimoxystrobin, without updated risk assessments, to be illegal. This decision, prompted by a case brought forth by the NGO PAN Europe, signals a significant shift in how the EU manages pesticide approvals, potentially impacting public health and environmental safety.
The Court emphasized that the European Commission cannot systematically issue extensions for pesticide approvals when there are delays in the reevaluation process. This clarification arises from the observation that substances such as glyphosate, boscalid, and dimoxystrobin have benefited from repeated extensions, often without thorough risk assessments being conducted.
NGOs had previously challenged the European Commission's decision to prolong the approval of dimoxystrobin before the Court. Although EU law mandates that pesticide safety assessments occur every 10 to 15 years, many products experience evaluation delays that extend beyond a decade. The ruling asserts that automatic and repeated extensions are unlawful, emphasizing that such extensions must be based on actual progress made in risk assessment protocols.
Spokespersons from PAN Europe stated that the ruling is crucial in preventing delays from incomplete applications, allowing toxic substances to remain on the market. They emphasized the importance of prioritizing health and environmental safety in pesticide regulations and noted that failing to meet risk assessment timelines has extended exposure to harmful pesticides.
The ruling is part of a broader trend in legal victories against the European Commission's pesticide approval processes. In previous years, the EU Court of Justice has also ruled against the systematic dereliction of regulations regarding banned pesticides, as well as the requirement to consider the latest independent scientific evidence during reevaluations.
In 2021 alone, the European Commission granted 136 authorizations for hazardous pesticides, accounting for nearly 30% of all active substances approved in the EU. PAN Europe identified two primary reasons for the delays in the review process: the submission of incomplete dossiers by industry stakeholders, which member states often overlook, and a lack of personnel dedicated to risk assessments, despite the potential for government fees to bolster resources.
As the EU grapples with the implications of this ruling, many are hopeful that it will lead to a more rigorous and transparent approach to pesticide regulation, prioritizing the health of citizens and the environment in future decision-making processes.
Sources:





